Precision Optics Stock Price, News & Analysis

Precision Optics (NASDAQ: POCI) reported Q4 and FY 2025 financial results, with record Q4 revenue of $6.2 million, up 48% year-over-year. FY 2025 revenue was $19.1 million, with production revenue growing 34% to $14.2 million. The company reported a net loss of $(5.8) million for FY 2025.

For FY 2026, POCI projects revenue exceeding $25 million (31% growth) and expects gross margins to improve to approximately 30% from 18% in FY 2025. The company anticipates Adjusted EBITDA of $0.5 million in FY 2026, compared to $(3.7) million in FY 2025.

Additionally, POCI appointed Joseph Traut as new Chief Operating Officer effective October 1, 2025, granting him inducement stock options for 60,000 shares.

Precision Optics (Nasdaq: POCI), a leading designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, has scheduled its fourth quarter and fiscal year 2025 financial results conference call for September 29, 2025, at 5:00 p.m. ET.

The company will release its financial results and file its 10-K after market close on the same day. Investors can join via phone at (844) 735-3662 or (412) 317-5705, or through a live webcast. A replay will be available for seven days following the call.

Precision Optics (Nasdaq: POCI), a designer and manufacturer of advanced optical instruments for medical and defense/aerospace industries, will participate in the Lytham Partners 2025 Consumer & Technology Investor Summit on August 19, 2025.

The company's virtual presentation is scheduled for 9:30 a.m. ET and will be accessible through the conference website. A replay of the webcast will be available following the presentation.

Precision Optics Corporation (NASDAQ: POCI), a designer and manufacturer of advanced optical instruments, announced a strategic relocation of its corporate offices from Gardner, MA to Littleton, MA, effective August 1st, 2025. The move will separate corporate functions, including executive leadership, engineering, and business operations, from production facilities. This strategic decision allows for expanded production capabilities at the existing Gardner facility to address the company's record-high production backlog. Additionally, the new Littleton location, along with a facility in South Portland, Maine, positions the company to access a broader engineering talent pool for its product development initiatives.

Precision Optics Corporation (NASDAQ: POCI), a specialized manufacturer of advanced optical instruments for medical and defense/aerospace sectors, has announced its participation in the upcoming Lytham Partners Spring 2025 Investor Conference on May 29, 2025.

The company will deliver a webcast presentation at 10:15 a.m. ET and conduct one-on-one meetings with investors throughout the virtual event. Interested participants can access the webcast through the conference website or arrange individual meetings with management through Lytham Partners.

Precision Optics Corporation (NASDAQ: POCI) reported Q3 FY2025 financial results with significant challenges and strategic developments. Revenue declined to $4.2 million from $5.2 million year-over-year, with production revenue at $3.3 million and engineering revenue at $0.9 million. The company faced setbacks with gross margins dropping to 10.0% from 35.5%, resulting in a net loss of ($2.1) million. Despite challenges, POCI secured a Main Purchase Agreement with a top-tier aerospace company, guaranteeing minimum purchases of nearly $4 million annually through 2026. The company launched the Unity Imaging Platform for endoscopic imaging devices and completed a $5.1 million common stock offering. Production issues with a single-use cystoscope line were resolved, with doubled throughput after February restart. Management expects improved Q4 performance with sequential revenue growth and break-even or better adjusted EBITDA.

Precision Optics Corporation (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, has scheduled a conference call to discuss its third quarter fiscal year 2025 financial results on Thursday, May 15, 2025, at 5:00 p.m. ET.

The company will release its financial results and file its 10-Q after market close on the same day. Interested parties can join the call by dialing (844) 735-3662 or (412) 317-5705, or access the live webcast at the provided link. A replay will be available for seven days.

Precision Optics (NASDAQ: POCI), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, has announced its participation in the Planet MicroCap Showcase: VEGAS 2025.

The presentation is scheduled for Wednesday, April 23, 2025, at 4:00 p.m. Pacific Time (7:00 p.m. Eastern Time) at Track 3 – Chablis in the Paris Hotel & Casino, Las Vegas. Dr. Joe Forkey, CEO, will lead the presentation and conduct a Q&A session.

The company will also hold one-on-one meetings with interested parties on April 24, 2025. Investors can access the live presentation through the provided webcast link and schedule 1x1 meetings through Planet MicroCap representatives or the company's investor relations team.

Precision Optics (NASDAQ: POCI) has signed a Main Purchase Agreement with a leading aerospace company, solidifying their commercial partnership that began in September 2023. The agreement showcases significant growth with:

• $3.1 million in new orders received during the current calendar year
• Total program backlog of $6.6 million to be delivered over the next 12 months
• Nearly $4 million per year in minimum purchase commitments through calendar 2026

To meet increased demand, POCI has doubled its clean room production line capacity. The partnership leverages Precision Optics' proprietary manufacturing technology for commercial aerospace applications.